Remove Antibody Remove Clinical Research Remove Drug Trials
article thumbnail

CytoDyn scores $12M in legal battle win: A huge breakthrough for its antibody drug trials

BioPharma Reporter

Amid a period of clinical holds and legal tangles, the US antibody specialist CytoDyn has reached a settlement to resolve legal disputes with its former contract research organization (CRO) Amarex Clinical Research.

article thumbnail

Eli Lilly Designs P-Tau Biomarker Assay for Early Alzheimer’s Disease Diagnosis

The Pharma Data

We wanted a tau antibody that would bind to the expressed forms of tau, so we developed a very specific assay,” Dage said. The plasma assay elements include: Capture – a biotin-labeled anti-phosphor-thr217-tau antibody. Detection – a ruthenium-labeled isoform-specific anti-tau antibody.